Cargando…

Biological Activity and Intracellular Metabolism of ZD1694 in Human Leukemia Cell Lines with Different Resistance Mechanisms to Antifolate Drugs

The biological activity and cellular metabolism of ZD1694, a novel folate‐based thymidylate synthase (TS) inhibitor, were analyzed in a human leukemia cell line, MOLT‐3, and its antifolate‐resistant sublines with different mechanisms of resistance to methotrexate (MTX), trimetrexate (TMQ) and N(10)‐...

Descripción completa

Detalles Bibliográficos
Autores principales:	Takemura, Yuzuru, Kobayashi, Hiroyuki, Miyachi, Hayato, Gibson, William, Kimbell, Rosemary, Jackman, Ann L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 1996
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5921156/ https://www.ncbi.nlm.nih.gov/pubmed/8698629 http://dx.doi.org/10.1111/j.1349-7006.1996.tb00291.x

Ejemplares similares

Cytotoxicity of Trimetrexate against Antifolate‐resistant Human T‐Cell Leukemia Cell Lines Developed in Oxidized or Reduced Folate
por: Miyachi, Hayato, et al.
Publicado: (1997)

Mechanisms of acquired resistance to the quinazoline thymidylate synthase inhibitor ZD1694 (Tomudex) in one mouse and three human cell lines.
por: Jackman, A. L., et al.
Publicado: (1995)

Molecular characterisation of two cell lines selected for resistance to the folate-based thymidylate synthase inhibitor, ZD1694.
por: Freemantle, S. J., et al.
Publicado: (1995)

Effects of impaired renal function on the pharmacokinetics of raltitrexed (Tomudex ZD1694).
por: Judson, I., et al.
Publicado: (1998)

Comparison of plasma and tissue levels of ZD1694 (Tomudex), a highly polyglutamatable quinazoline thymidylate synthase inhibitor, in preclinical models.
por: Aherne, G. W., et al.
Publicado: (1998)

Differential Alterations of Dihydrofolate Reductase Gene in Human Leukemia Cell Lines Made Resistant to Various Folate Analogues
por: Miyachi, Hayato, et al.
Publicado: (1993)

Effect of Hammerhead Ribozyme against Human Thymidylate Synthase on the Cytotoxicity of Thymidylate Synthase Inhibitors
por: Kobayashi, Hiroyuki, et al.
Publicado: (1995)

A phase II study in advanced breast cancer: ZD1694 ('Tomudex') a novel direct and specific thymidylate synthase inhibitor.
por: Smith, I., et al.
Publicado: (1996)

Targeting intracellular p-aminobenzoic acid production potentiates the anti-tubercular action of antifolates
por: Thiede, Joshua M., et al.
Publicado: (2016)

1694 Risk factors and outcomes of isoniazid hepatotoxicity in children with latent tuberculosis
por: Devrim, Ilker, et al.
Publicado: (2014)

Vandetanib (ZD6474) in the Treatment of Medullary Thyroid Cancer
por: Deshpande, Hari, et al.
Publicado: (2011)

ZD6474 – clinical experience to date
por: Heymach, J V
Publicado: (2005)

P1694: THROMBOSIS RISK ASSESSMENT IN LYMPHOMA PATIENTS - PROSPECTIVE PILOT SUDY
por: Antic, D., et al.
Publicado: (2022)

The renal effects of the water-soluble, non-folylpolyglutamate synthetase-dependent thymidylate synthase inhibitor ZD9331 in mice.
por: Walton, M. I., et al.
Publicado: (1998)

Induction of apoptosis by the ADEPT agent ZD2767: comparison with the classical nitrogen mustard chlorambucil and a monofunctional ZD2767 analogue
por: Monks, N R, et al.
Publicado: (2001)

The Higgs as a portal to the hidden sector via an analysis of $H\to Zd_d Z_d \to 4l$ using the ATLAS detector
por: Unwuchola, D A
Publicado: (2015)

1694. Joint Fluid Cell Count of Septic Arthritis Patients Diagnosed with Positive Culture in Children
por: Otsubo, Yuto, et al.
Publicado: (2023)

Chiral evasion and stereospecific antifolate resistance in Staphylococcus aureus
por: Wang, Siyu, et al.
Publicado: (2022)

Sextons' day books for 1685-1687 and 1694-1703 from the parish of St. Martin-in-the-Fields, London.
por: Forbes, T. R.
Publicado: (1973)

The Impact of Short-Term, Intensive Antifolate Treatment (with Pyrimethamine and Sulfadoxine) and Antibiotics Followed by Long-Term, Secondary Antifolate Prophylaxis on the Rate of Toxoplasmic Retinochoroiditis Recurrence
por: Borkowski, Piotr K., et al.
Publicado: (2016)

Prevalence of antifolate resistance mutations in Plasmodium falciparum isolates in Afghanistan
por: Awab, Ghulam R, et al.
Publicado: (2013)

Antifolate Agents Against Wild and Mutant Strains of Plasmodium falciparum
por: Shaikh, M. S., et al.
Publicado: (2014)

The Role of Folate Transport in Antifolate Drug Action in Trypanosoma brucei
por: Dewar, Simon, et al.
Publicado: (2016)

Factors Influencing the Antifolate Activity of Synthetic Tea-Derived Catechins
por: Sáez-Ayala, Magalí, et al.
Publicado: (2013)

Folate transporter dynamics and therapy with classic and tumor-targeted antifolates
por: O’Connor, Carrie, et al.
Publicado: (2021)

1694P Discovery of circulating biomarkers in COVID-19 patients undergoing anti-IL6R immunotherapy
por: Michot, J-M., et al.
Publicado: (2020)

1694. Predictors of Septic Shock in Adult Patients with Candidemia: A Single-Center Experience Over 13 Years
por: Woong Suh, Jin, et al.
Publicado: (2019)

Autophagy inhibition induces enhanced proapoptotic effects of ZD6474 in glioblastoma
por: Shen, J, et al.
Publicado: (2013)

The accumulation of rare-earth yttrium ions by Penicillium sp. ZD28
por: Wang, Weiying, et al.
Publicado: (2020)

Synthesis and Biological Evaluation of 2,4-Diaminopyrimidine-Based Antifolate Drugs against Bacillus anthracis
por: Nammalwar, Baskar, et al.
Publicado: (2014)

Unlocking the Molecular Secrets of Antifolate Drug Resistance: A Multi-Omics Investigation of the NCI-60 Cell Line Panel
por: Rushing, Blake R.
Publicado: (2023)

Submicroscopic Gametocytes and the Transmission of Antifolate-Resistant Plasmodium falciparum in Western Kenya
por: Oesterholt, Mayke J. A. M., et al.
Publicado: (2009)

Propargyl-Linked Antifolates are Dual Inhibitors of Candida albicans and Candida glabrata
por: G-Dayanandan, Narendran, et al.
Publicado: (2014)

Differential chemosensitivity to antifolate drugs between RAS and BRAF melanoma cells
por: Arozarena, Imanol, et al.
Publicado: (2014)

Structure-Guided In Vitro to In Vivo Pharmacokinetic Optimization of Propargyl-Linked Antifolates
por: Lombardo, M.N., et al.
Publicado: (2019)

Repurposing benzbromarone as antifolate to develop novel antifungal therapy for Candida albicans
por: Mujwar, Somdutt, et al.
Publicado: (2022)

Gefitinib (‘Iressa’, ZD1839) and new epidermal growth factor receptor inhibitors
por: Blackledge, G, et al.
Publicado: (2004)

ZD6474 reverses multidrug resistance by directly inhibiting the function of P-glycoprotein
por: Freshney, R I
Publicado: (2007)

ZD6474 reverses multidrug resistance by directly inhibiting the function of P-glycoprotein
por: Mi, Y, et al.
Publicado: (2007)

ZD6474 – a novel inhibitor of VEGFR and EGFR tyrosine kinase activity
por: Ryan, A J, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_gmiltjdlnadu7dm11dv92brfer